HB1006 modifies Colorado’s Health Insurance Affordability Enterprise to address individual-market health insurance affordability, especially if federal enhanced premium tax credits are not extended for the 2026 plan year. The bill creates a contingent state backstop that would allow the enterprise to use up to $100 million in proceeds from newly authorized tax-credit sales to support affordability efforts, with up to $50 million directed to the reinsurance program and up to $50 million directed to carrier subsidies that lower premiums for people who buy exchange plans and receive the premium tax credit. It also allows up to $5 million of those proceeds to be used for other enterprise purposes, excluding administrative costs, and adds a $10 million transfer from an ARPA refinance account to the health insurance affordability cash fund.
The bill also expands and restructures the enterprise’s funding and oversight framework. It authorizes the sale of insurance premium tax credits and corporate income tax credits to insurers and C corporations, with the proceeds credited to the health insurance affordability cash fund and, after a cap is reached, to the general fund. It creates or amends multiple statutory provisions governing how credits are sold, transferred, claimed, and reported, and it sets up a new tax credit sale proceeds cash fund to cover administrative costs. The bill further requires annual reporting on enterprise revenues, allocations, and surplus funds, and it directs a performance audit of the enterprise by the State Auditor by the end of 2027.
HB1006 is highly contingent on federal action. If Congress does not extend or recreate the enhanced premium tax credit by December 31, 2025, the new state funding and tax-credit mechanisms take effect on January 1, 2026. If Congress does extend the enhanced premium tax credit with at least the same eligibility and amount as under the American Rescue Plan Act and Inflation Reduction Act, the new provisions are repealed. The bill also amends the state’s reserve calculation rules to account for the new funding transfer mechanism if the contingent state program becomes active.
The general sentiment reflected in the vote history appears supportive but not unanimous. The bill advanced through both chambers and ultimately passed, with several committee votes showing clear majorities and final floor votes showing meaningful support in both the House and Senate. At the same time, the recorded no votes at multiple stages indicate that some members were concerned about the bill’s structure, fiscal exposure, or policy approach. The absence of committee transcripts limits more detailed insight into the debate.
The main points of contention appear to be the bill’s reliance on contingent tax-credit financing, the possibility of using general fund money if tax-credit sale proceeds fall short, and the broader question of whether the state should create a backup affordability program tied to uncertain federal policy. Supporters likely viewed the bill as a way to protect consumers from premium increases and preserve affordability tools like reinsurance and subsidies; opponents likely focused on the complexity of the financing mechanism, the use of state resources, and the uncertainty created by the federal trigger and repeal provisions.
The bill amends Colorado statutes governing the Health Insurance Affordability Enterprise, the health insurance affordability cash fund, and related tax-credit and budget-reserve provisions. It creates new authority for the state to sell insurance premium tax credits and corporate income tax credits, establishes new cash-fund and reporting requirements, and adds contingent funding allocations for reinsurance and individual-market premium reductions. It also changes the state reserve formula in the event the contingent funding structure takes effect and requires a future performance audit and regulatory review of the enterprise.
Overall sentiment appears generally favorable, with the bill advancing through committee and floor votes in both chambers and ultimately passing. The vote margins suggest broad support for the goal of improving health insurance affordability, but the presence of several dissenting votes at each stage indicates that the bill was not universally embraced. The lack of transcript material makes it difficult to identify specific arguments, but the recorded votes suggest a mix of support for consumer affordability and caution about the bill’s financing and contingent design.
The most notable contention centers on the bill’s financing model and its dependence on whether federal enhanced premium tax credits are extended. Some legislators likely supported the bill as a necessary state fallback to keep individual-market coverage affordable, while others likely questioned the use of tax-credit sales, the possibility of general fund backfill, and the complexity of creating a contingent program that could later be repealed. There also appears to have been some concern about how much money should go to reinsurance versus direct carrier subsidies, and about the level of oversight and reporting needed to ensure the enterprise uses funds effectively.